Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Neurocrine Biosciences Cash on Hand 2010-2023 | NBIX

Neurocrine Biosciences cash on hand from 2010 to 2023. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Neurocrine Biosciences cash on hand for the quarter ending December 31, 2023 was $1.032B, a 4.28% increase year-over-year.
  • Neurocrine Biosciences cash on hand for 2023 was $1.032B, a 4.28% increase from 2022.
  • Neurocrine Biosciences cash on hand for 2022 was $0.989B, a 39.08% increase from 2021.
  • Neurocrine Biosciences cash on hand for 2021 was $0.711B, a 11.2% decline from 2020.
  
Neurocrine Biosciences Annual Cash on Hand
(Millions of US $)
2023 $1,032
2022 $989
2021 $711
2020 $801
2019 $671
2018 $651
2017 $516
2016 $307
2015 $379
2014 $194
2013 $146
2012 $173
2011 $129
2010 $127
2009 $53
Neurocrine Biosciences Quarterly Cash on Hand
(Millions of US $)
2023-12-31 $1,032
2023-09-30 $1,095
2023-06-30 $977
2023-03-31 $895
2022-12-31 $989
2022-09-30 $799
2022-06-30 $648
2022-03-31 $665
2021-12-31 $711
2021-09-30 $766
2021-06-30 $885
2021-03-31 $874
2020-12-31 $801
2020-09-30 $945
2020-06-30 $948
2020-03-31 $772
2019-12-31 $671
2019-09-30 $670
2019-06-30 $620
2019-03-31 $524
2018-12-31 $651
2018-09-30 $635
2018-06-30 $509
2018-03-31 $460
2017-12-31 $516
2017-09-30 $511
2017-06-30 $525
2017-03-31 $236
2016-12-31 $307
2016-09-30 $353
2016-06-30 $387
2016-03-31 $382
2015-12-31 $379
2015-09-30 $377
2015-06-30 $385
2015-03-31 $370
2014-12-31 $194
2014-09-30 $180
2014-06-30 $195
2014-03-31 $220
2013-12-31 $146
2013-09-30 $157
2013-06-30 $154
2013-03-31 $158
2012-12-31 $173
2012-09-30 $174
2012-06-30 $178
2012-03-31 $181
2011-12-31 $129
2011-09-30 $112
2011-06-30 $115
2011-03-31 $122
2010-12-31 $127
2010-09-30 $125
2010-06-30 $131
2010-03-31 $66
2009-12-31 $53
2009-09-30 $57
2009-06-30 $53
2009-03-31 $66
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $14.281B $1.887B
Neurocrine Biosciences is a neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. The company's neuroscience, endocrine and immunology disciplines provide a unique biological understanding of the molecular interaction between central nervous, immune and endocrine systems for the development of therapeutic interventions for anxiety, depression, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity and diabetes.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.263B 32.23
Chugai Pharmaceutical (CHGCY) Japan $51.982B 23.24
Takeda Pharmaceutical (TAK) Japan $42.124B 8.53
Merck (MKGAF) Germany $23.587B 22.87
Astellas Pharma (ALPMY) Japan $17.518B 27.66
Sandoz Group AG (SDZNY) Switzerland $15.512B 0.00
Shionogi (SGIOY) Japan $13.629B 11.85
United Therapeutics (UTHR) United States $12.075B 12.87
Catalent (CTLT) United States $9.999B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.716B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.965B 7.66
Revolution Medicines (RVMD) United States $6.433B 0.00
Orion OYJ (ORINY) Finland $5.645B 23.81
Ionis Pharmaceuticals (IONS) United States $5.491B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.628B 0.00
Alpine Immune Sciences (ALPN) United States $4.456B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.094B 0.00
Summit Therapeutics (SMMT) United States $3.166B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.105B 0.00
Corcept Therapeutics (CORT) United States $2.867B 25.98
PTC Therapeutics (PTCT) United States $2.610B 0.00
Dyne Therapeutics (DYN) United States $2.512B 0.00
Indivior (INDV) United States $2.391B 11.33
Recursion Pharmaceuticals (RXRX) United States $2.232B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.083B 11.84
Evotec AG (EVO) Germany $1.946B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.937B 18.85
Fusion Pharmaceuticals (FUSN) Canada $1.825B 0.00
Ardelyx (ARDX) United States $1.813B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.804B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.586B 27.76
Avadel Pharmaceuticals (AVDL) Ireland $1.532B 0.00
Soleno Therapeutics (SLNO) United States $1.526B 0.00
Pacira BioSciences (PCRX) United States $1.467B 13.94
Xencor (XNCR) United States $1.385B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.335B 0.00
4D Molecular Therapeutics (FDMT) United States $1.326B 0.00
Cronos Group (CRON) Canada $1.154B 0.00
Enliven Therapeutics (ELVN) United States $1.120B 0.00
Collegium Pharmaceutical (COLL) United States $1.102B 6.59
Ironwood Pharmaceuticals (IRWD) United States $1.039B 16.19
Cassava Sciences (SAVA) United States $1.034B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.012B 0.00
Ocular Therapeutix (OCUL) United States $0.971B 0.00
USANA Health Sciences (USNA) United States $0.924B 15.11
ARS Pharmaceuticals (SPRY) United States $0.882B 0.00
ProKidney (PROK) United States $0.869B 0.00
Relay Therapeutics (RLAY) United States $0.864B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.823B 0.00
Sage Therapeutics (SAGE) United States $0.723B 0.00
Lyell Immunopharma (LYEL) United States $0.709B 0.00
Silence Therapeutics (SLN) United Kingdom $0.687B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.656B 0.00
Savara (SVRA) United States $0.652B 0.00
Altimmune (ALT) United States $0.631B 0.00
Exscientia (EXAI) United Kingdom $0.620B 0.00
Harrow (HROW) United States $0.572B 0.00
Siga Technologies (SIGA) United States $0.562B 7.18
Verve Therapeutics (VERV) United States $0.536B 0.00
OmniAb (OABI) United States $0.533B 0.00
Bioventus (BVS) United States $0.525B 20.09
KalVista Pharmaceuticals (KALV) United States $0.509B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.491B 0.00
Esperion Therapeutics (ESPR) United States $0.491B 0.00
Heron Therapeutics (HRTX) United States $0.485B 0.00
Korro Bio (KRRO) United States $0.475B 0.00
Larimar Therapeutics (LRMR) United States $0.474B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.467B 0.00
Lexeo Therapeutics (LXEO) United States $0.462B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.388B 0.00
Tourmaline Bio (TRML) United States $0.385B 0.00
Organogenesis (ORGO) United States $0.378B 71.25
Nanobiotix S.A (NBTX) France $0.342B 0.00
Nektar Therapeutics (NKTR) United States $0.331B 0.00
Fractyl Health (GUTS) United States $0.320B 0.00
Xeris Biopharma Holdings (XERS) United States $0.299B 0.00
Aquestive Therapeutics (AQST) United States $0.299B 0.00
Black Diamond Therapeutics (BDTX) United States $0.295B 0.00
Nature's Sunshine Products (NATR) United States $0.292B 18.58
ESSA Pharma (EPIX) Canada $0.277B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.277B 0.00
Metagenomi (MGX) United States $0.262B 0.00
Foghorn Therapeutics (FHTX) United States $0.247B 0.00
Pyxis Oncology (PYXS) United States $0.246B 0.00
Aldeyra Therapeutics (ALDX) United States $0.243B 0.00
Akebia Therapeutics (AKBA) United States $0.239B 0.00
Eliem Therapeutics (ELYM) United States $0.238B 0.00
Prelude Therapeutics (PRLD) United States $0.235B 0.00
Conduit Pharmaceuticals (CDT) United States $0.217B 0.00
Profound Medical (PROF) Canada $0.207B 0.00
Avita Medical (RCEL) United States $0.204B 0.00
Century Therapeutics (IPSC) United States $0.203B 0.00
Zevra Therapeutics (ZVRA) United States $0.199B 0.00
Galectin Therapeutics (GALT) United States $0.195B 0.00
Adherex Technologies (FENC) United States $0.195B 237.33
Acrivon Therapeutics (ACRV) United States $0.194B 0.00
Telomir Pharmaceuticals (TELO) United States $0.183B 0.00
VAXART, INC (VXRT) United States $0.180B 0.00
CytoDyn (CYDY) United States $0.178B 0.00
Incannex Healthcare (IXHL) Australia $0.176B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Achieve Life Sciences (ACHV) Canada $0.174B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.172B 0.00
MediWound (MDWD) Israel $0.164B 0.00
Cardiol Therapeutics (CRDL) Canada $0.161B 0.00
Elite Pharmaceuticals (ELTP) United States $0.148B 13.90
OptiNose (OPTN) United States $0.146B 0.00
Context Therapeutics (CNTX) United States $0.135B 0.00
Karyopharm Therapeutics (KPTI) United States $0.134B 0.00
Regulus Therapeutics (RGLS) United States $0.131B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.124B 8.32
FibroGen (FGEN) United States $0.123B 0.00
Citius Pharmaceuticals (CTXR) United States $0.121B 0.00
PMV Pharmaceuticals (PMVP) United States $0.111B 0.00
Vivani Medical (VANI) United States $0.108B 0.00
Relmada Therapeutics (RLMD) United States $0.105B 0.00
ProPhase Labs (PRPH) United States $0.097B 0.00
Assertio Holdings (ASRT) United States $0.097B 4.43
SCYNEXIS (SCYX) United States $0.091B 1.28
AlloVir (ALVR) United States $0.086B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Aclaris Therapeutics (ACRS) United States $0.084B 0.00
Jaguar Animal Health (JAGX) United States $0.079B 0.00
Protara Therapeutics (TARA) United States $0.077B 0.00
Journey Medical (DERM) United States $0.072B 0.00
Tempest Therapeutics (TPST) United States $0.072B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.071B 0.00
Mural Oncology (MURA) Ireland $0.066B 0.00
Champions Oncology (CSBR) United States $0.064B 0.00
Carisma Therapeutics (CARM) United States $0.057B 0.00
Inotiv (NOTV) United States $0.056B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.055B 0.00
Nutriband (NTRB) United States $0.052B 0.00
BioLineRx (BLRX) Israel $0.051B 0.00
Gain Therapeutics (GANX) United States $0.049B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.048B 0.00
ElectroCore (ECOR) United States $0.044B 0.00
CASI Pharmaceuticals (CASI) China $0.043B 0.00
Natural Alternatives (NAII) United States $0.042B 0.00
VYNE Therapeutics (VYNE) United States $0.039B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
Unicycive Therapeutics (UNCY) United States $0.039B 0.00
NRx Pharmaceuticals (NRXP) United States $0.038B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
Surrozen (SRZN) United States $0.032B 0.00
Viracta Therapeutics (VIRX) United States $0.032B 0.00
JanOne (JAN) United States $0.031B 0.00
Lipocine (LPCN) United States $0.031B 0.00
DURECT (DRRX) United States $0.029B 0.00
Aptorum Group (APM) United Kingdom $0.026B 0.00
Oncternal Therapeutics (ONCT) United States $0.026B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
TherapeuticsMD (TXMD) United States $0.024B 0.00
Lyra Therapeutics (LYRA) United States $0.022B 0.00
PolyPid (PYPD) Israel $0.021B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.021B 0.00
Indaptus Therapeutics (INDP) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Talphera (TLPH) United States $0.020B 0.00
Alaunos Therapeutics (TCRT) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.020B 0.75
GlycoMimetics (GLYC) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.017B 0.00
CERo Therapeutics Holdings (CERO) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
Plus Therapeutics (PSTV) United States $0.013B 0.00
Dominari Holdings (DOMH) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.011B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Avalo Therapeutics (AVTX) United States $0.010B 0.00
Molecular Templates (MTEM) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.009B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Mangoceuticals (MGRX) United States $0.005B 0.00
Clever Leaves Holdings (CLVR) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Finch Therapeutics (FNCH) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Avenue Therapeutics (ATXI) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.96
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 35.44